Mark Robert Keaton
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 10
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 2
- Lung Cancer Research Studies 1
-
- Lung Cancer Treatments and Mutations 2
- Renal cell carcinoma treatment 1
- Co-authors
- Barry C. Mirtsching (2 shared papers)Thomas M. Cosgriff (2 shared papers)Myo Min (2 shared papers)Graydon Harker (2 shared papers)Tarek A. Chidiac (2 shared papers)Barrett H. Childs (2 shared papers)John Daniel Hainsworth (2 shared papers)Axel F. Grothey (1 shared paper)
- Journals
- Clinical Breast Cancer (4 papers)Investigational New Drugs (2 papers)Genes & Diseases (1 paper)Clinical Cancer Research (1 paper)Lung Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Mark Robert Keaton
12 papers receiving 758 citations
Mark Robert Keaton's Hit Papers
Peers
Comparison fields: 5 of 52
- Oncology 529
- Cancer Research 200
- Pulmonary and Respiratory Medicine 192
- Radiology, Nuclear Medicine and Imaging 104
- Genetics 41
Countries citing papers authored by Mark Robert Keaton
This map shows the geographic impact of Mark Robert Keaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Robert Keaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Robert Keaton more than expected).
Fields of papers citing papers by Mark Robert Keaton
This network shows the impact of papers produced by Mark Robert Keaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Robert Keaton. The network helps show where Mark Robert Keaton may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Robert Keaton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 461 |
| 2 | 2011 | 59 | |
| 3 | 2013 | 58 | |
| 4 | 2014 | 52 | |
| 5 | 2011 | 50 | |
| 6 | 2011 | 27 | |
| 7 | 2017 | 19 | |
| 8 | 2011 | 16 | |
| 9 | 2014 | 12 | |
| 10 | 2009 | 10 | |
| 11 | 2017 | 5 | |
| 12 | 1990 | 2 |
About Mark Robert Keaton
Mark Robert Keaton is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 12 papers that have together received 771 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (4 papers), Lung Cancer Treatments and Mutations (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (1 paper), Chemotherapy-induced cardiotoxicity and mitigation (1 paper), Renal cell carcinoma treatment (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Oncology (529 citations), Cancer Research (200 citations), Pulmonary and Respiratory Medicine (192 citations), Radiology, Nuclear Medicine and Imaging (104 citations) and Genetics (41 citations). Mark Robert Keaton has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Barry C. Mirtsching, Thomas M. Cosgriff, Myo Min, Graydon Harker, Tarek A. Chidiac, Barrett H. Childs, John Daniel Hainsworth, Axel F. Grothey, Howard S. Höchster and Eric Keith Rowinsky. Their work appears in journals such as Clinical Breast Cancer, Investigational New Drugs, Genes & Diseases, Clinical Cancer Research and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.